Selexipag (Uptravi)

BNF:: Not lsited
Status:: Red
Decision Date:: October 2016

Comments

In line with NHSE commissioning intentions.

Red Drug Classifications

2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)